Captor Therapeutics Spolka Akcyjna

WSE:CTX Rapporto sulle azioni

Cap. di mercato: zł377.7m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Captor Therapeutics Spolka Akcyjna Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Tom Shepherd

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO3.6yrs
Proprietà del CEO1.3%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione2.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

Here's Why We're Not Too Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

Jul 13
Here's Why We're Not Too Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth

Mar 10
We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth

We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn

Oct 03
We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn

Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

Mar 13
Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth

Jun 15
Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth

AMMINISTRATORE DELEGATO

Tom Shepherd

3.6yrs

Mandato

Dr. Thomas Shepherd, Ph D also known as Tom, is Chief Executive Officer at Captor Therapeutics spolka akcyjna and serves as Executive Chairman of Captor Therapeutics's Swiss affiliate, with responsibility...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Charles Kunsch
Independent Member of the Supervisory Board1.3yrsNessun datoNessun dato
Andrew Saunders
Chief Medical Officer1.6yrsNessun datoNessun dato
Pawel Holsten
Chairman of the Supervisory Board6yrsNessun dato7.72%
PLN 29.2m
Robert Florczykowski
Independent Member of the Supervisory Board2.6yrsNessun datoNessun dato
Krzysztof Samotij
Independent Member of the Supervisory Boardno dataNessun dato0.13%
PLN 503.9k
Maciej Wroblewski
Member of the Supervisory Board3.4yrsNessun dato0.13%
PLN 503.9k

2.6yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di CTX non è considerato esperto (durata media del mandato 2.6 anni), il che suggerisce un nuovo consiglio.